Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BYRN - US12448X2018 - Common Stock

16.07 USD
-0.67 (-4%)
Last: 12/29/2025, 5:07:52 PM
16.05 USD
-0.02 (-0.12%)
After Hours: 12/29/2025, 5:07:52 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BYRN. BYRN was compared to 71 industry peers in the Aerospace & Defense industry. BYRN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BYRN shows excellent growth, but is valued quite expensive already. These ratings could make BYRN a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BYRN had positive earnings in the past year.
BYRN had a negative operating cash flow in the past year.
BYRN had negative earnings in 4 of the past 5 years.
In multiple years BYRN reported negative operating cash flow during the last 5 years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

With an excellent Return On Assets value of 20.36%, BYRN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 25.33%, BYRN belongs to the best of the industry, outperforming 94.37% of the companies in the same industry.
The Return On Invested Capital of BYRN (14.57%) is better than 92.96% of its industry peers.
Industry RankSector Rank
ROA 20.36%
ROE 25.33%
ROIC 14.57%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

BYRN has a Profit Margin of 14.43%. This is amongst the best in the industry. BYRN outperforms 91.55% of its industry peers.
BYRN's Operating Margin of 10.81% is fine compared to the rest of the industry. BYRN outperforms 71.83% of its industry peers.
With an excellent Gross Margin value of 61.32%, BYRN belongs to the best of the industry, outperforming 91.55% of the companies in the same industry.
In the last couple of years the Gross Margin of BYRN has grown nicely.
Industry RankSector Rank
OM 10.81%
PM (TTM) 14.43%
GM 61.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BYRN is still creating some value.
BYRN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BYRN has been increased compared to 5 years ago.
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BYRN has an Altman-Z score of 16.49. This indicates that BYRN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 16.49, BYRN belongs to the best of the industry, outperforming 92.96% of the companies in the same industry.
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.49
ROIC/WACC1.46
WACC10.01%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

BYRN has a Current Ratio of 4.21. This indicates that BYRN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.21, BYRN is in the better half of the industry, outperforming 76.06% of the companies in the same industry.
BYRN has a Quick Ratio of 1.71. This is a normal value and indicates that BYRN is financially healthy and should not expect problems in meeting its short term obligations.
BYRN has a Quick ratio of 1.71. This is in the better half of the industry: BYRN outperforms 60.56% of its industry peers.
Industry RankSector Rank
Current Ratio 4.21
Quick Ratio 1.71
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

BYRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 235.00%, which is quite impressive.
Looking at the last year, BYRN shows a very strong growth in Revenue. The Revenue has grown by 50.99%.
The Revenue has been growing by 147.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)235%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)50.99%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%35.13%

3.2 Future

Based on estimates for the next years, BYRN will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.16% on average per year.
Based on estimates for the next years, BYRN will show a quite strong growth in Revenue. The Revenue will grow by 18.79% on average per year.
EPS Next Y-31.89%
EPS Next 2Y5.3%
EPS Next 3Y11.16%
EPS Next 5YN/A
Revenue Next Year37.51%
Revenue Next 2Y28.62%
Revenue Next 3Y24.73%
Revenue Next 5Y18.79%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.99, which indicates a rather expensive current valuation of BYRN.
83.10% of the companies in the same industry are more expensive than BYRN, based on the Price/Earnings ratio.
BYRN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.92.
BYRN is valuated rather expensively with a Price/Forward Earnings ratio of 23.38.
Based on the Price/Forward Earnings ratio, BYRN is valued cheaper than 80.28% of the companies in the same industry.
BYRN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.46.
Industry RankSector Rank
PE 23.99
Fwd PE 23.38
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BYRN's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.41
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The decent profitability rating of BYRN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.3%
EPS Next 3Y11.16%

0

5. Dividend

5.1 Amount

BYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (12/29/2025, 5:07:52 PM)

After market: 16.05 -0.02 (-0.12%)

16.07

-0.67 (-4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)12-08 2025-12-08/bmo
Earnings (Next)04-01 2026-04-01
Inst Owners65.06%
Inst Owner Change-0.42%
Ins Owners17.26%
Ins Owner Change-11.25%
Market Cap365.27M
Revenue(TTM)110.85M
Net Income(TTM)16.00M
Analysts83.64
Price Target40.49 (151.96%)
Short Float %22.42%
Short Ratio8.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.45%
Min EPS beat(2)21.04%
Max EPS beat(2)37.87%
EPS beat(4)4
Avg EPS beat(4)102.42%
Min EPS beat(4)21.04%
Max EPS beat(4)254.68%
EPS beat(8)7
Avg EPS beat(8)85.45%
EPS beat(12)9
Avg EPS beat(12)5.69%
EPS beat(16)10
Avg EPS beat(16)-7.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)-0.77%
Revenue beat(4)1
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)1.52%
Revenue beat(8)4
Avg Revenue beat(8)7.51%
Revenue beat(12)4
Avg Revenue beat(12)-0.39%
Revenue beat(16)5
Avg Revenue beat(16)-1.7%
PT rev (1m)0%
PT rev (3m)3.12%
EPS NQ rev (1m)-6.03%
EPS NQ rev (3m)1.37%
EPS NY rev (1m)-2.01%
EPS NY rev (3m)10.7%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)1.95%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 23.99
Fwd PE 23.38
P/S 3.3
P/FCF N/A
P/OCF N/A
P/B 5.78
P/tB 6.33
EV/EBITDA 26.41
EPS(TTM)0.67
EY4.17%
EPS(NY)0.69
Fwd EY4.28%
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS4.88
BVpS2.78
TBVpS2.54
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.47
Profitability
Industry RankSector Rank
ROA 20.36%
ROE 25.33%
ROCE 18.44%
ROIC 14.57%
ROICexc 16.91%
ROICexgc 18.72%
OM 10.81%
PM (TTM) 14.43%
GM 61.32%
FCFM N/A
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score7
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 340.6%
Cap/Sales 6.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.21
Quick Ratio 1.71
Altman-Z 16.49
F-Score7
WACC10.01%
ROIC/WACC1.46
Cap/Depr(3y)202.29%
Cap/Depr(5y)309.93%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)235%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next Y-31.89%
EPS Next 2Y5.3%
EPS Next 3Y11.16%
EPS Next 5YN/A
Revenue 1Y (TTM)50.99%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%35.13%
Revenue Next Year37.51%
Revenue Next 2Y28.62%
Revenue Next 3Y24.73%
Revenue Next 5Y18.79%
EBIT growth 1Y601.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year246.09%
EBIT Next 3Y84.52%
EBIT Next 5Y53.44%
FCF growth 1Y-82.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.34%
OCF growth 3YN/A
OCF growth 5YN/A

BYRNA TECHNOLOGIES INC / BYRN FAQ

What is the ChartMill fundamental rating of BYRNA TECHNOLOGIES INC (BYRN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BYRN.


Can you provide the valuation status for BYRNA TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 3 / 10 to BYRNA TECHNOLOGIES INC (BYRN). This can be considered as Overvalued.


How profitable is BYRNA TECHNOLOGIES INC (BYRN) stock?

BYRNA TECHNOLOGIES INC (BYRN) has a profitability rating of 6 / 10.


What is the earnings growth outlook for BYRNA TECHNOLOGIES INC?

The Earnings per Share (EPS) of BYRNA TECHNOLOGIES INC (BYRN) is expected to decline by -31.89% in the next year.